Inventor
Ingo Hartung
Inventor
Berlin, DE
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds4%
C07JSteroids2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
PatentTitleYear
10,919,862Fused imidazoles as mIDH1 inhibitors202110,662,185Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use202010,052,312Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use20189,776,997'3-aryl-substituted imidazo[1,2-A]pyridines and their use'20179,624,214'Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20179,487,554'Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments'20169,422,285'Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof'20169,126,998'Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20158,993,630'Substituted sulphonamido phenoxybenzamides'20158,962,606'Substituted benzosulphonamides'20158,946,215'Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20158,796,305'Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20148,778,964'Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use'20148,642,611'Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'20148,524,724'Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'20138,481,539'Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'20138,003,655'Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'20117,846,928'Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'20107,825,128'Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs'20107,825,114'Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'20107,795,264'Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2011Patents assigned to BAYER SCHERING PHARMA AG (5)· patent assignee history
2010–2021Based in Berlin, DE· patent location history
2013–2016Patents assigned to BAYER IP GMBH (5)· patent assignee history
2013–2015Patents assigned to HARTUNG INGO (4)· patent assignee history
2013–2014Patents assigned to BOEMER ULF (2)· patent assignee history
2013–2015Based in Erkrath, DE· patent location history
2014–2021Patents assigned to Bayer Pharma AG (11)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 11 | 2014–2021 |
| BAYER IP GMBH | 5 | 2013–2016 |
| BAYER SCHERING PHARMA AG | 5 | 2010–2011 |
| HARTUNG INGOself | 4 | 2013–2015 |
| BOEMER ULF | 2 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 19 | 2010–2021 |
| Erkrath, DE | 2 | 2013–2015 |